These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37718524)

  • 1. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
    Francesconi V; Rizzo M; Schenone S; Carbone A; Tonelli M
    Curr Med Chem; 2024; 31(15):1955-1982. PubMed ID: 37718524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.
    Pacheco PAF; Santos MMM
    Molecules; 2022 Jan; 27(1):. PubMed ID: 35011552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.
    Zucca M; Scutera S; Savoia D
    Curr Med Chem; 2013; 20(4):502-26. PubMed ID: 23210775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
    Navarro M; Gabbiani C; Messori L; Gambino D
    Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparasitic therapy.
    Kappagoda S; Singh U; Blackburn BG
    Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
    Njogu PM; Guantai EM; Pavadai E; Chibale K
    ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents.
    Ribeiro R; Costa L; Pinto E; Sousa E; Fernandes C
    Mar Drugs; 2023 Nov; 21(12):. PubMed ID: 38132930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
    Sánchez-Delgado RA; Anzellotti A
    Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
    Fournet A; Muñoz V
    Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of QSAR studies to discover new drug-like compounds actives against leishmaniasis and trypanosomiasis.
    Castillo-Garit JA; Abad C; Rodríguez-Borges JE; Marrero-Ponce Y; Torrens F
    Curr Top Med Chem; 2012; 12(8):852-65. PubMed ID: 22352913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recent update on new synthetic chiral compounds with antileishmanial activity.
    Verboni M; Olivieri D; Lucarini S
    Chirality; 2022 Oct; 34(10):1279-1297. PubMed ID: 35947400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-1,3,4-thiadiazoles as prospective agents in trypanosomiasis and other parasitoses.
    Serban G
    Acta Pharm; 2020 Sep; 70(3):259-290. PubMed ID: 32074064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New drugs for the treatment of human parasitic protozoa].
    Dupouy-Camet J
    Parassitologia; 2004 Jun; 46(1-2):81-4. PubMed ID: 15305692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium Metallotherapeutics: Novel Approaches to Combatting Parasitic Infections.
    Britten NS; Butler JA
    Curr Med Chem; 2022 Aug; 29(31):5159-5178. PubMed ID: 35366762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmaniasis: current treatment and prospects for new drugs and vaccines.
    Kedzierski L; Sakthianandeswaren A; Curtis JM; Andrews PC; Junk PC; Kedzierska K
    Curr Med Chem; 2009; 16(5):599-614. PubMed ID: 19199925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
    Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.